WHITEHAWK THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- WHITEHAWK THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 24.29K shares, a 788.95% increase year-over-year.
- WHITEHAWK THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 0.00 shares, a 100.00% decline year-over-year.
- WHITEHAWK THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 0.00 shares.
- WHITEHAWK THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 0.00 shares.
- WHITEHAWK THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 24.94K shares.
- WHITEHAWK THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 0.00 shares, a 100.00% decline from fiscal 2023.
- WHITEHAWK THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 41.63K shares, a 68.48% decline from fiscal 2022.
- WHITEHAWK THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 132.08K shares, a 82.65% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 24.29K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 24.29K shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-07 | 2.73K shares derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 24.94K shares 10-K · filed 2026-03-12 |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | 24.94K shares derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-06-30 | 2.73K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | 24.94K shares derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-03-31 | 22.20K shares 10-Q · filed 2025-05-08 | 22.20K shares derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 0.00 shares 10-K · filed 2026-03-12 |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | 0.00 shares derived: sum of 4 quarters · filed 2024-11-06 |
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | 6.00K shares derived: sum of 4 quarters · filed 2024-08-07 |
| 2024-03-31 | 0.00 shares 10-Q · filed 2024-05-08 | 39.65K shares derived: sum of 4 quarters · filed 2024-05-08 |
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | 41.63K shares 10-K · filed 2024-03-13 |
| 2023-09-30 | 6.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | 54.32K shares derived: sum of 4 quarters · filed 2023-11-08 |
| 2023-06-30 | 33.65K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | 53.08K shares derived: sum of 4 quarters · filed 2023-08-09 |
| 2023-03-31 | 1.98K shares 10-Q · filed 2023-05-10 | 94.29K shares derived: sum of 4 quarters · filed 2023-05-10 |
| 2022-12-31 | 12.69K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | 132.08K shares 10-K · filed 2023-03-29 |
| 2022-09-30 | 4.76K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | 130.64K shares derived: sum of 4 quarters · filed 2022-11-09 |
| 2022-06-30 | 74.86K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | 94.60K shares derived: sum of 4 quarters · filed 2022-08-10 |
| 2022-03-31 | 39.78K shares 10-Q · filed 2022-05-12 | 33.33K shares derived: sum of 4 quarters · filed 2022-05-12 |
| 2021-12-31 | 11.24K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | 72.32K shares 10-K · filed 2022-03-17 |
| 2021-09-30 | -31.28K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | |
| 2021-06-30 | 13.59K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | |
| 2021-03-31 | 78.77K shares 10-Q · filed 2021-05-17 | |
| 2020-12-31 | 139.66K shares 10-K · filed 2021-03-11 | |
| 2019-12-31 | 0.00 shares 10-K · filed 2021-03-11 | |
| 2018-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | 52.10K shares 10-K · filed 2020-03-16 |
| 2018-09-30 | 34.30K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | 52.10K shares derived: sum of 4 quarters · filed 2019-03-07 |
| 2018-06-30 | 1.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | 17.80K shares derived: sum of 4 quarters · filed 2019-03-07 |
| 2018-03-31 | 16.80K shares 10-Q · filed 2018-05-15 | |
| 2017-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | 25.73K shares 10-K · filed 2019-03-07 |
| 2017-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | |
| 2016-12-31 | 21.87K shares 10-K · filed 2018-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |